Impact of ongoing COVID-19 pandemic on cytology: An institutional experience

Chanchal Rana1, Sumit Kumar2, Suresh Babu1

  • 1Department of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India.

Diagnostic Cytopathology
|September 24, 2020
PubMed

Insights

The COVID-19 lockdown in India caused a 92.6% drop in cytology samples, with a significant decrease in thyroid cases. Malignancy rates increased, highlighting the pandemic's impact on diagnostic services.

Area of Science:

  • Medical Diagnostics
  • Pathology
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted global health services.
  • Established medical practices faced unprecedented challenges worldwide.
  • Healthcare systems required rapid adaptation to new protocols.

Purpose of the Study:

  • To document the institutional experience and impact of the COVID-19 pandemic on cytology services.
  • To analyze changes in sample volume and diagnostic patterns during the lockdown period.
  • To compare pre-pandemic and lockdown-period cytology data.

Main Methods:

  • Cytology samples received during India's COVID-19 lockdown (March 24 - May 17, 2020) were analyzed.
  • Data was compared to samples received during the same period in 2019.
  • Statistical analysis was performed to assess significant changes.

Main Results:

  • A substantial 92.6% overall reduction in cytology samples was observed.
  • Thyroid cytology samples showed a statistically significant decrease (P=0.023).
  • Malignancy rates increased by 34.1%, with a decrease in neoplastic cases; breast and lymph node samples showed a relative, non-significant increase.

Conclusions:

  • Cytology services experienced a dramatic decline in sample volume during the COVID-19 lockdown.
  • The pandemic led to an increased malignancy rate in the reduced sample pool.
  • Effective sample prioritization, safety precautions, and patient triaging enabled safe procedure execution.
Abstract